Companies › FEMY
FEMASYS INC (FEMY)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001339005 · EDGAR filings · Updated 2026-06-24
FEMASYS INC (FEMY) has reported institutional ownership of 15.7%, with 36 institutional managers holding positions valued at $3.98M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-24 — Current report (8-K) filed
- 2026-06-24 — Current report (8-K) filed
- 2026-06-05 — Current report (8-K) filed
- 2026-06-04 — Current report (8-K) filed
- 2026-05-13 — Current report (8-K) filed
- 2026-05-08 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, FEMASYS INC has 36 institutional holders and institutional ownership of 15.7%.
Insider activity
Insiders reported 6 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
YD BIO LTD (YDES) · DYADIC INTL INC DEL (DYAI) · OS THERAPIES INCORPORATED (OSTX) · Incannex Healthcare Inc (IXHL) · PRECIPIO INC (PRPO) · BRIACELL THERAPEUTICS CORP (BCTX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-24.